Home/Nuclivision/Jeremy De Sy

JD

Jeremy De Sy

CCO

Therapeutic Areas

Oncology Neurology

Nuclivision Pipeline

Drug	Indication	Phase
NUCLARITY®	Oncologic and Neurologic PET Imaging	Commercial
Coming Soon Solution	Nuclear Medicine Workflow	Development

Leadership Team at Nuclivision

Maarten Larmuseau

Cofounder & CEO

Cofounder & COO

Cofounder & CTO

Prof. Roland Hustinx, MD

View full Nuclivision profile